IQVIA Holdings Inc.
IQVIA Holdings Inc.
IQV
Valuace
15
Růst
78
Zdraví
50
Cena
$ 211.92
Dnes
--3.60 (-1.49%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
36.1B
Obrat
16B
Zisk
1B
Aktiva
29B
Dluh
15B
ROE
0%
ROA
0%
PE
21
PS
2
Cena 1R
135-247
⌀ Cena
186.79
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
05-02-2026
Poslední dividenda

Profil

IQVIA Holdings Inc. poskytuje pokročilou analytickou, technologická řešení a klinické výzkumné služby průmyslu biologických věd v Americe, Evropě, Africe a Asii-Pacifiku. Působí ve třech segmentech: technologická a analytická řešení, řešení pro výzkum a vývoj a smluvní prodejní a zdravotnická řešení. Segment Technology & Analytics Solutions nabízí řadu cloudových aplikací a souvisejících implementačních služeb, řešení v reálném světě, která umožňují vědám o živé přírodě a zákazníkům poskytovatelů vytvářet a šířit důkazy, které informují o rozhodování v oblasti zdravotní péče a zlepšují výsledky pacientů, a strategické a implementační konzultační služby, jako jsou pokročilé analytické a komerční procesy outsourcingové služby. Tento segment také poskytuje výkonnostní metriky na úrovni jednotlivých zemí související s prodejem farmaceutických výrobků, trendy předepisování, lékařskou péčí a propagační činností napříč různými kanály, včetně maloobchodního prodeje, nemocničního prodeje a zásilkového prodeje, a měření prodeje nebo předepisování na regionální úrovni, na úrovni PSČ a na úrovni jednotlivých předepisujících osob. Segment Research & Development Solutions nabízí projektový management a klinické monitorování, podporu klinických testů, virtuální testy a služby strategického plánování a designu, stejně jako centrální laboratorní, genomické, bioanalytické, ADME, discovery a vakcinační a biomarkerové laboratorní služby. Segment Prodej a lékařská řešení smlouvy poskytuje služby pro poskytovatele zdravotní péče a zapojení pacientů a služby v oblasti vědecké strategie a lékařských záležitostí. Slouží farmaceutickým, biotechnologickým, přístrojovým a diagnostickým a spotřebitelským zdravotnickým společnostem. Společnost strategicky spolupracuje se společností HealthCore, Inc. Společnost byla dříve známá jako Quintiles IMS Holdings, Inc. a v listopadu 2017 změnila svůj název na IQVIA Holdings Inc. IQVIA Holdings Inc. byla založena v roce 1982 a sídlí v Durhamu v Severní Karolíně.
Sektor
Healthcare
Odvětví
Medical - Diagnostics & Research
Počet zaměstnanců
89000
Založení
2013-05-09
Adresa
4820 Emperor boulevard
CEO
Ari Bousbib

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues16.3116.3115.4114.9814.4113.8711.3611.0910.419.746.885.745.465.104.874.333.92
Cost of Revenues12.0212.0210.039.759.389.237.507.306.756.304.754.143.983.763.633.192.80
Gross Profit4.294.295.385.245.034.643.863.793.673.442.131.601.481.341.231.141.12
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues4.364.104.023.833.963.903.813.743.913.74
Cost of Revenues4.072.732.692.532.582.522.762.442.792.43
Gross Profit0.291.371.321.301.381.381.061.291.121.31
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
Selling General & Admin Expenses0.000.000.002.052.071.961.791.731.721.611.010.920.880.860.820.760.70
Depreciation & Amortization1.141.141.111.131.141.421.411.321.141.010.290.130.120.110.100.090.08
Total Operating Expenses2.002.003.172.053.203.233.082.942.862.621.300.920.880.860.820.760.70
Operating Income2.292.292.201.981.801.390.730.780.740.720.640.650.590.460.400.350.40
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.000.000.000.000.000.000.000.000.000.00
Selling General & Admin Expenses0.000.000.000.000.000.000.000.000.560.50
Depreciation & Amortization0.320.290.280.270.300.280.270.260.320.30
Total Operating Expenses-0.440.820.820.800.750.830.510.790.560.80
Operating Income0.730.550.510.500.630.550.550.510.560.48
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income0.050.050.050.040.010.010.010.010.010.010.000.000.000.000.000.000.00
Interest Expense0.730.730.670.670.420.380.420.450.410.350.140.100.100.120.130.110.14
Other Expense-0.67-0.67-0.53-0.52-0.44-0.27-0.36-0.43-0.08-0.15-0.21-0.040.00-0.03-0.02-0.09-0.04
IBT1.611.611.671.461.361.130.370.350.330.330.480.540.500.320.270.180.24
Income Tax Expense0.250.250.300.100.260.160.070.120.06-0.990.350.160.150.100.090.020.08
Net Income1.361.361.371.361.090.970.280.190.261.310.120.390.360.230.180.240.16
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.010.010.010.010.010.010.010.010.010.01
Interest Expense0.190.190.180.170.170.170.160.170.190.18
Other Expense-0.16-0.15-0.18-0.19-0.08-0.20-0.11-0.17-0.13-0.13
IBT0.570.410.320.310.550.350.440.340.370.35
Income Tax Expense0.060.080.060.060.110.070.080.05-0.100.05
Net Income0.510.330.270.250.440.290.360.290.470.30
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$7.39$5.82$5.05$1.46$0.98$1.27$6.01$0.77$3.15$2.78$1.83$1.42$1.93$1.28
EPS Diluted$0.00$0.00$0.00$7.29$5.72$4.95$1.43$0.96$1.24$5.88$0.76$3.08$2.72$1.77$1.39$1.90$1.26
Shares Outstanding0.170.170.180.180.190.190.190.200.200.220.150.120.130.120.130.130.13
Diluted Shares Outstanding0.170.170.180.190.190.200.200.200.210.220.150.130.130.130.130.130.13
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$2.58$1.66
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$2.54$1.63
Shares Outstanding0.170.170.170.180.180.180.180.180.180.18
Diluted Shares Outstanding0.170.170.170.180.180.180.180.180.180.19
Current Assets TTM 20242023202220212020201920182017201620152014201320122011
Cash And Equivalents1.551.701.381.221.371.810.840.890.961.200.980.870.780.570.52
Short Term Investments0.130.140.120.090.110.090.060.050.050.04-0.03-0.03-0.04-0.04-0.02
Total Cash & ST Investments1.681.841.501.311.481.900.900.941.011.240.980.870.780.570.52
Accounts Receivable3.303.243.412.962.612.472.642.462.041.741.201.020.940.760.72
Inventory0.000.000.000.150.160.160.140.150.150.120.150.170.140.110.08
Other Current Assets0.650.750.690.560.520.560.450.320.260.240.080.090.090.070.05
Total Current Assets5.625.835.604.984.765.094.133.873.453.342.412.151.951.511.37
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents1.812.041.741.701.571.551.441.381.221.38
Short Term Investments0.160.150.140.140.140.130.130.120.110.11
Total Cash & ST Investments1.972.191.881.841.711.681.581.501.331.49
Accounts Receivable3.313.413.313.243.253.303.463.413.283.18
Inventory0.000.000.000.000.000.000.000.000.180.18
Other Current Assets0.690.750.720.750.670.650.620.690.600.65
Total Current Assets5.986.355.915.835.635.625.655.605.215.33
Long-Term Assets TTM 20242023202220212020201920182017201620152014201320122011
Net Property, Plant & Equipment0.770.770.820.860.900.950.950.430.440.410.190.190.200.190.19
Goodwill14.4814.7114.5713.9213.3012.6512.1611.8011.8510.730.720.460.410.300.28
Intangible Assets4.614.504.844.824.945.215.515.956.596.390.370.280.300.270.27
Long-Term Investments0.290.370.240.160.160.160.150.140.080.080.090.070.060.060.03
Other Long-Term Assets0.480.520.460.470.490.390.230.240.240.180.110.120.120.130.11
Total Long-Term Assets20.7821.0721.0920.3619.9319.4719.1318.6819.2917.871.511.161.120.990.96
Total Assets26.4026.9026.6825.3424.6924.5623.2522.5522.7421.213.933.313.072.502.32
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment0.820.820.770.770.770.770.790.820.790.83
Goodwill15.9515.6115.0314.7115.0914.4814.5214.5714.2914.18
Intangible Assets4.714.604.504.504.734.614.734.844.914.94
Long-Term Investments0.410.410.380.370.320.290.260.240.210.21
Other Long-Term Assets0.470.510.490.520.470.480.480.450.460.44
Total Long-Term Assets22.7522.2921.4121.0721.5520.7820.9221.0920.7720.71
Total Assets28.7328.6327.3226.9027.1826.4026.5726.6825.9826.04
Current Liabilities TTM 20242023202220212020201920182017201620152014201320122011
Accounts Payable3.310.740.713.322.982.812.510.440.320.250.150.110.100.080.07
Short-Term Debt1.171.150.830.150.090.150.100.100.100.090.050.000.010.060.02
Other Current Liabilities0.333.143.040.310.340.340.321.991.751.590.820.820.830.720.70
Current Liabilities6.626.966.495.585.244.563.953.532.902.711.591.471.481.321.19
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable3.553.403.560.743.433.313.460.713.133.01
Short-Term Debt2.161.311.221.151.221.170.720.931.311.34
Other Current Liabilities2.680.610.323.140.350.140.212.940.140.14
Current Liabilities8.517.577.186.966.996.626.456.496.596.54
Long-Term Liabilities TTM 20242023202220212020201920182017201620152014201320122011
Long-Term Debt12.0913.0113.4112.8612.3512.7611.9410.9110.127.112.422.292.042.371.95
Capital Leases0.190.170.450.260.310.370.400.000.000.000.000.000.000.000.00
Def. Tax Liability0.150.200.200.460.410.340.650.740.922.130.070.060.040.010.01
Total Liabilities19.6820.8320.5719.5718.6518.2816.9915.6014.3812.354.264.013.733.863.29
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt13.0314.3913.2913.0112.4812.2813.0213.4112.5412.68
Capital Leases0.230.210.180.170.190.190.200.450.220.24
Def. Tax Liability0.210.220.200.200.130.150.160.200.370.37
Total Liabilities22.4422.8521.3420.8320.2119.6820.2320.5720.1720.29
Total Common Equity TTM 20242023202220212020201920182017201620152014201320122011
Common Stock0.000.000.0010.9010.7811.1011.0510.9010.7810.600.010.140.480.000.00
Retained Earnings5.346.074.693.332.241.281.000.810.66-0.40-0.46-0.79-1.15-1.37-0.99
Comprehensive Income-0.95-1.04-0.87-0.73-0.41-0.21-0.31-0.220.05-0.57-0.11-0.060.000.010.02
Total Common Equity6.716.076.115.776.046.006.006.718.118.63-0.34-0.70-0.67-1.36-0.97
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.000.000.000.000.000.000.000.0010.9910.95
Retained Earnings6.916.586.316.075.635.344.984.694.223.92
Comprehensive Income-0.93-0.88-0.98-1.04-0.83-0.95-0.91-0.87-0.90-0.76
Total Common Equity6.165.785.986.076.976.716.346.115.815.75
Other TTM 20242023202220212020201920182017201620152014201320122011
Total Debt13.4514.1614.2313.0112.4412.9012.0411.0110.237.202.472.292.052.421.97
Book Value6.716.076.115.776.046.286.266.958.368.86-0.34-0.70-0.67-1.36-0.97
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.130.010.010.000.000.000.000.000.000.00
Book Value6.165.785.986.076.976.716.346.115.815.75
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income1.421.361.371.361.090.970.310.230.281.330.130.390.360.230.180.240.17
Depreciation & Amortization1.151.141.111.131.131.261.291.201.141.010.290.130.120.110.100.090.08
Stock-Based Compensation0.200.250.210.220.190.170.100.150.110.110.080.040.030.020.030.010.02
Change Working Capital-0.050.130.16-0.28-0.080.680.460.02-0.11-0.290.21-0.07-0.050.060.01-0.080.10
Change In Accounts Receivable-0.170.060.18-0.39-0.42-0.140.26-0.12-0.30-0.14-0.06-0.25-0.08-0.15-0.06-0.120.00
Change In Accounts Payable0.27-0.100.120.270.430.240.250.240.370.090.160.100.050.110.060.070.04
Change In Inventories0.120.000.000.000.00-0.02-0.23-0.12-0.18-0.140.060.02-0.030.03-0.040.02-0.02
Other Non-cash Items1.17-0.04-0.010.000.04-0.01-0.01-0.020.000.030.01-0.03-0.020.010.01-0.030.02
Cash from Operations2.440.000.002.152.262.941.961.421.250.970.860.480.430.400.340.160.38
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income0.510.330.270.250.440.290.360.290.470.30
Depreciation & Amortization0.320.290.280.270.300.280.270.260.320.30
Stock-Based Compensation0.000.060.060.070.050.050.050.060.050.05
Change Working Capital-0.040.45-0.100.000.110.15-0.08-0.020.07-0.02
Change In Accounts Receivable-0.380.170.140.13-0.080.070.120.07-0.25-0.11
Change In Accounts Payable0.000.000.000.000.000.000.000.000.270.00
Change In Inventories0.000.000.000.000.000.000.000.000.120.00
Other Non-cash Items-0.01-0.17-0.010.020.01-0.010.000.000.000.01
Cash from Operations0.000.000.000.000.000.000.000.000.750.58
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-0.610.00-0.60-0.65-0.67-0.64-0.62-0.58-0.46-0.37-0.16-0.08-0.08-0.09-0.07-0.08-0.08
Acquisitions-0.63-1.71-0.71-0.88-1.34-1.46-0.17-0.59-0.33-0.831.870.02-0.10-0.15-0.05-0.14-0.10
Investments-0.08-0.02-0.13-0.08-0.01-0.01-0.01-0.03-0.030.00-0.04-0.010.000.00-0.01-0.03-0.01
Sales of Investment-0.040.000.000.000.000.010.00-0.020.460.000.040.000.010.000.000.000.02
Other Investing Activities0.010.000.000.010.010.010.000.03-0.460.000.020.000.000.000.000.020.03
Cash from Investing-1.320.000.00-1.60-2.01-2.10-0.80-1.19-0.81-1.191.73-0.07-0.17-0.24-0.13-0.22-0.14
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-0.170.29-0.15-0.14-0.16-0.15-0.14-0.15-0.18-0.15
Acquisitions-0.92-0.46-0.20-0.15-0.09-0.43-0.05-0.14-0.01-0.43
Investments-0.020.000.00-0.02-0.06-0.02-0.02-0.03-0.030.00
Sales of Investment0.000.000.000.000.000.000.000.00-0.040.00
Other Investing Activities0.000.000.000.000.000.000.000.000.040.00
Cash from Investing0.000.000.000.000.000.000.000.00-0.21-0.57
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-0.920.000.000.80-2.66-2.69-2.50-3.68-3.06-4.65-1.95-2.06-0.18-2.45-2.00-1.72-0.10
Debt Issued0.3514.16-0.082.023.232.233.364.713.847.686.682.240.432.072.453.690.10
Issuance of Common Stock-0.060.000.000.000.000.000.000.000.020.090.100.060.040.530.001.980.00
Repurchase of Common Stock-0.32-1.24-1.35-0.99-1.17-0.41-0.45-0.95-1.41-2.62-1.10-0.52-0.42-0.01-0.01-0.01-0.01
Dividends Paid0.000.000.000.000.000.000.000.00-4.08-7.16-0.64-2.25-0.43-2.07-0.57-0.29-0.07
Other Financing Activities0.310.000.00-0.193.501.862.734.358.0814.271.314.510.864.072.43-0.020.02
Cash from Financing-0.930.000.00-0.38-0.33-1.24-0.22-0.28-0.45-0.07-2.28-0.25-0.130.07-0.15-0.06-0.15
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.000.000.000.000.000.000.000.00-0.160.01
Debt Issued15.19-0.511.190.350.460.25-0.29-0.490.54-0.16
Issuance of Common Stock0.000.000.000.000.000.000.000.000.000.00
Repurchase of Common Stock-0.211.03-0.66-0.38-1.15-0.200.000.00-0.23-0.14
Dividends Paid0.000.000.000.000.000.000.000.000.000.00
Other Financing Activities0.000.000.000.000.000.000.000.00-0.04-0.01
Cash from Financing0.000.000.000.000.000.000.000.00-0.42-0.14
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash0.160.280.330.16-0.15-0.450.98-0.05-0.07-0.240.220.110.090.210.05-0.130.08
Closing Cash Balance1.551.981.701.381.221.371.810.840.890.961.200.980.870.780.570.520.65
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash0.17-0.230.300.040.130.030.100.070.15-0.16
Closing Cash Balance1.981.812.041.741.701.571.551.441.381.22
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow1.832.052.111.501.592.301.340.840.800.600.700.400.350.310.260.090.30
Real Free Cash Flow1.631.801.911.281.392.131.250.690.680.500.620.360.320.280.240.070.28
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow0.561.200.290.430.720.570.450.380.570.44
Real Free Cash Flow0.561.150.230.350.670.520.400.320.520.39
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E2174.463
P/S1.72.757.8
P/B4.55.629.8
P/FCF12.430.8549.4
Market cap$36.1$33.4
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %51.6 %0 %
Debt to Income1116.9 %2487.3 %0 %
Debt to Free cash flow662.5 %12.5 %0 %
Interest expense percentage31.9 %34.5 %2.9 %
Current ratio0.7 1.1 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE22.1 %-13.4 %0 %
ROA4.7 %4.7 %0 %
CapEx to Revenue1.1 %3.3 %0 %
RaD to Revenue0 %0 %0 %
ROEM185,340.9 118604

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin26.3 %31.3 %47.8 %
Operating margin14 %9.9 %28 %
Net margin8.3 %5.9 %19.8 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %1.1 %0 %
Dividend payout percentage0 %422.8 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding171.9 mil 172.6 mil
Employee count88.0 tis 61.4 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader